- CA$645.61m
- CA$154.26m
- $53.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.84 | ||
| Price to Tang. Book | 0.98 | ||
| Price to Free Cashflow | 1.37 | ||
| Price to Sales | 6.83 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.95% | ||
| Return on Equity | -23.66% | ||
| Operating Margin | -224.16% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.35 | 10.68 | 8.63 | 17.04 | 53.41 | 71.38 | 91.96 | 16.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -37.38 | +968.17 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aventus Capital Inc., formerly The Westaim Corporation, is an integrated insurance and alternative asset management company consisting of Ceres Life and CCaventus. Ceres Life is an artificial intelligence (AI) native annuity insurance company. CCaventus is a global institutional asset manager with expertise in credit and asset-oriented investments. CCaventus invests in corporate, real estate and structured finance opportunities. The Company provides permanent capital to its multi-asset management platform, enabling firms with experience in insurance asset management to achieve risk-adjusted returns.
Directors
- Ian Delaney CHM
- J. Cameron Macdonald CEO
- Glenn Macneil CFO
- Robert Kittel COO
- Stephen Cole LED (69)
- John Gildner IND
- Lisa Mazzocco IND
- Kevin Parker IND
- Bruce Walter IND (63)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- December 31st, 2024
- Public Since
- July 4th, 1996
- No. of Employees
- 7
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
TSX Venture Exchange- Shares in Issue
- 33,244,549
- Address
- 200 Park Avenue, 58th Floor, NEW YORK, 10166
- Web
- https://www.aventuscapital.com
- Phone
- +1 4169693333
- Auditors
- Deloitte & Touche LLP
Latest News for AVTS
Upcoming Events for AVTS
Q3 2026 Westaim Corp Earnings Release
Q4 2026 Westaim Corp Earnings Release
Similar to AVTS
49 North Resources
TSX Venture Exchange
AI Artificial Intelligence Ventures
TSX Venture Exchange
Alset AI Ventures
TSX Venture Exchange
AmeriTrust Financial Technologies
TSX Venture Exchange
Bitcoin Well
TSX Venture Exchange
FAQ
As of Today at 01:28 UTC, shares in Aventus Capital are trading at CA$19.42. This share price information is delayed by 15 minutes.
Shares in Aventus Capital last closed at CA$19.42 and the price had moved by -29.21% over the past 365 days. In terms of relative price strength the Aventus Capital share price has underperformed the Toronto Stock Exchange 300 Composite Index by -40.33% over the past year.
The overall consensus recommendation for Aventus Capital is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAventus Capital does not currently pay a dividend.
Aventus Capital does not currently pay a dividend.
Aventus Capital does not currently pay a dividend.
To buy shares in Aventus Capital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$19.42, shares in Aventus Capital had a market capitalisation of CA$645.61m.
Here are the trading details for Aventus Capital:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: AVTS
Based on an overall assessment of its quality, value and momentum Aventus Capital is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Aventus Capital is CA$28.95. That is 49.06% above the last closing price of CA$19.42.
Analysts covering Aventus Capital currently have a consensus Earnings Per Share (EPS) forecast of -$7.04 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aventus Capital. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -25.34%.
As of the last closing price of CA$19.42, shares in Aventus Capital were trading -15.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aventus Capital PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$19.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aventus Capital's management team is headed by:
- Ian Delaney - CHM
- J. Cameron Macdonald - CEO
- Glenn Macneil - CFO
- Robert Kittel - COO
- Stephen Cole - LED
- John Gildner - IND
- Lisa Mazzocco - IND
- Kevin Parker - IND
- Bruce Walter - IND